drugset / Trial / NCT02201420
Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study (NAV3-12) is to determine the dissemination and localization of Tc 99m tilmanocept by SPECT and SPECT/CT imaging in subjects with confirmed cutaneous KS. This is a single center, open-label, within-subject study.
Timeline
- Start
- 2014-09
- Primary completion
- 2015-03
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tilmanocept | Diagnostic / imaging agent | 50 ug | — |
| Subject | Tilmanocept | Diagnostic / imaging agent | 74 mbq | — |